| Aβ | Peptide amyloid β |
| ATP | Adenosine triphosphate |
| BBB | Blood–brain barrier |
| CSF | Cerebrospinal fluid |
| CXCL | Chemokine (C-X-C motif) ligand |
| DAMPs | Damage or danger-associated molecular patterns |
| EVD | External ventricular drain |
| GFAP | Glial fibrillary acidic protein |
| HMGB1 | High mobility group protein 1 |
| IL | Interleukin |
| IS | Ischemic stroke |
| MLKL | Mixed-lineage kinase domain-like pseudokinase |
| MSR1 | Macrophage scavenger receptor 1 |
| NF-κB | Nuclear factor-kappa B |
| NO | Nitric oxide |
| NOD | Nucleotide oligomerization domain |
| NSE | Neuron-specific enolase |
| PRRs | Pattern-recognition receptors |
| RAGE | Receptor for advanced glycation end-products |
| sRAGE | Soluble form of the receptor for advanced glycation end-products |
| RIPK | Receptor-interacting protein kinase |
| SAH | Subarachnoid hemorrhage |
| SD | Spreading depolarization |
| TBI | Traumatic brain injury |
| TNF | Tumor necrosis factor |
| TNFR1 | Tumor necrosis factor receptor 1 |
| TLRs | Toll-like receptors |